Frutarom Backs Away From Large M&A, Citing Expensive Valuations
(Bloomberg) -- Israeli flavor maker Frutarom Industries Ltd., which this week announced the purchase of a French competitor, is shelving plans for large deals to focus on smaller companies with cheaper valuations, according to its chief executive.
The company aims to nearly double its sales in four years, with acquisitions playing a key role in that push, Ori Yehudai said in an interview in Frutarom's Herzliya office. Industry consolidation has driven up valuations, making bigger targets less attractive, he said, days before Tuesday's announcement that the company would buy France's René Laurent SAS for $21 million.
“There aren't many large targets. You can count them on two hands,” Yehudai said. Frutarom has abandoned a plan to list shares in the U.S. to fund such big deals, he added.
The ingredients market is dominated by four companies, led by Givaudan SA and Firmenich International SA, both based in Switzerland. The strongest companies have been buying smaller competitors to drive growth amid economic downturns in emerging markets such as Russia and Brazil.
Commando Staff
That strategy has driven up the price of deals, sometimes to as much as five times annual sales, according to Duncan Fox, a Bloomberg Intelligence analyst. In its own acquisitions, Frutarom pays about seven times earnings before interest, tax, depreciation and amortization, Yehudai said.
Frutarom's “commando” M&A staff is currently doing due diligence or negotiating purchase prices with about 20 small family-owned or founder-run companies.
"When we talk about doubling our size every four or five years -- which we were able to do in the last 20 years -- we don't need to do large acquisitions," Yehudai said. "We acquired $220 million of revenue in the last two years and we will buy $150 million more every year. We're producing nice cash flow."
The René Laurent deal is Frutarom's 21st since the beginning of 2015. Among them was the purchase of Austrian flavor company Wiberg GmbH for about $130 million in December 2015, the largest deal in Frutarom's history.
The company says acquiring other companies will boost sales by 75 percent to $2 billion by 2020.
Though they laud its skill in buying companies, analysts have questioned Frutarom's ability to integrate the new businesses. The company's EBITDA margin has stayed flat at about 18 percent since 2013, according to data compiled by Bloomberg. That trails market leaders such as Givaudan, International Flavors & Fragrances Inc. and Symrise AG.
Yehudai said Frutarom's focus is on serving their small customers, not necessarily squeezing every dollar out of the business model.
“Mid-size local customers don't get the same level of service and attention and support that the big food companies get from our big competitors,” he said. “We can give them this kind of support."
Growth Areas
More than 75 percent of Frutarom's 40,000 customers are small, local businesses, which Yehudai says will help the company grow faster than its peers. The private-label sector -- local farmers and manufacturers who sell food that's then branded by grocery chains like Lidl Ltd. and Tesco Plc -- is growing by 5 percent a year, as opposed to 2 percent for larger food brands like Nestle SA, according to Yehudai. Private-label customers generate about a quarter of Frutarom sales.
"The bigger companies aren't growing at the moment and the smaller ones are," Gil Dattner, equity analyst at Bank Leumi Le-Israel Ltd., said in a phone interview. "Frutarom has good exposure to growth areas, and management has a good track record of acquiring companies when the valuations aren't very high."
Still, Dattner has a sell rating on Frutarom because he believes stocks generally are overvalued. Frutarom shares were up 4.3 percent this year as of 3:40 p.m. Tuesday in Tel Aviv, compared to a 5.3 percent drop in the TA-35 index. Frutarom stock fell 6 percent in 2016, its first losing year since 2011.
Yehudai wants to ramp up dealmaking in Asia and double operations there to about 15 percent of sales within the next two to three years. Frutarom bought its first company in India in 2015, and Yehudai says the company has identified some 400 potential targets in China. Emerging markets accounted for about 40 percent of revenue last year, exceeding Western Europe for the first time, according to Yehudai.
"Emerging markets should be over 50 percent" of sales, he said. "It's impossible to want to grow 5 percent internally when you have half of your sales in Western Europe, which isn't growing at all."
To contact the reporter on this story: Yaacov Benmeleh in Tel Aviv at ybenmeleh@bloomberg.net.
To contact the editors responsible for this story: Dale Crofts at dcrofts@bloomberg.net, Michael S. Arnold, Amy Teibel
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.